Target intelligence / Profile preview

RNA, U1 small nuclear 149, pseudogene (RNU1-149P)

Target
RNU1-149P
Molecular classification
Other (pseudogene; non-coding RNA)
01

Overview

RNA, U1 small nuclear 149, pseudogene (RNU1-149P) is a member of the U1 small nuclear RNA (snRNA) pseudogene family, annotated as a non-coding RNA locus. Pseudogenes like RNU1-149P bear sequence similarity to the canonical U1 snRNA, which is an essential part of the spliceosome complex responsible for pre-mRNA splicing[1][5]. Unlike functional U1 snRNA genes, pseudogenes typically possess mutations that prevent them from encoding a fully functional RNA or contributing directly to canonical spliceosomal activity[5]. However, research indicates that some U1 snRNA pseudogenes can be transcribed and incorporated into ribonucleoprotein complexes, potentially exerting regulatory effects on gene expression and mRNA processing in a cell- or stage-specific manner[5]. There is no current evidence that RNU1-149P has direct therapeutic relevance or is a target for pharmacological modulation. Its classification as a pseudogene means it is generally not considered a therapeutic target, receptor, enzyme, transporter, or similar actionable molecule[1][5].

Other names
RNU1-149PRNA, U1 small nuclear 149, pseudogene
02

Mechanism of action

Not applicable

03

Biological functions

Other (no proven direct biological function specific for RNU1-149P, but related U1 snRNA pseudogenes can be transcribed and may influence RNA processing)
04

Disease associations

Other (no direct disease roles ascribed to RNU1-149P specifically, but some U1 snRNA pseudogenes have been found differentially expressed in cell types or developmental stages, potentially contributing to broader RNA regulatory mechanisms)[5]

Beyond the preview

Go deeper on RNA, U1 small nuclear 149, pseudogene (RNU1-149P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 149, pseudogene (RNU1-149P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call